Search Results - "Sanchez‐Avila, F."

Effect of Pentoxifylline on Levels of Pro‐inflammatory Cytokines During Chronic Hepatitis C by Gutierrez‐Reyes, G., Lopez‐Ortal, P., Sixtos, S., Cruz, S., Ramirez‐Iglesias, M. T., Gutierrez‐Ruiz, M. C., Sanchez‐Avila, F., Roldan, E., Vargas‐Vorackova, F., Kershenobich, D.

“…The cellular and humoral natural immune response induced by hepatitis C virus (HCV) is commonly unable to eradicate the virus. HCV is a highly mutable,…”
Get full text

Atypical manifestations of hepatitis A virus infection by Muñoz-Martínez, S G, Díaz-Hernández, H A, Suárez-Flores, D, Sánchez-Ávila, J F, Gamboa-Domínguez, A, García-Juárez, I, Torre, A

“…Acute hepatitis due to the hepatitis A virus usually has a short, benign and self-limited course, without causing chronic hepatitis. However, some cases have…”
Get full text

Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation by Castells, Lluís, Vargas, Víctor, Rodríguez, Francisco, Allende, Helena, Buti, Maria, Sánchez-Avila, José F., Jardí, Rosendo, Margarit, Carlos, Pumarola, Tomás, Esteban, Rafael, Guardia, Jaime

“…De novo hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT) in patients negative for hepatitis B surface antigen (HBsAg) is between…”
Get full text

Risk factors associated with HCV co-infection amongst MSM and transgender women living with HIV in Mexico City: a case-control study by Ramirez-Gonzalez, Luis E., Camiro-Zúñiga, Antonio, Piñeirua- Menendez, Alicia, Sánchez-Avila, Juan F., Hirata-Hernández, A. Harumi, Marañón-Solorio, Karen A., Zamora-Tapia, Irwin, Pérez-Carrizosa, Areli, Simental-Aldaba, Emmanuel, Sierra-Madero, Juan G.

“…Hepatitis C virus infection (HCV) is a major cause of co-morbidity in people living with HIV (PLWHIV). The modes of HCV transmission in the local population of…”
Get full text

Tu1961 Microbial Analysis in High-Risk Patients With Acute Bacterial Cholangitis Treated in a Tertiary Care Center in Mexico City by Castro-Gomez, Jose F, Garcia-Juarez, Ignacio, Sanchez-Avila, Juan F

Get full text

Sa2036 Deficiency and Insufficiency of Magnesium and Vitamin D and Their Correlation With the Metabolic Profile After Liver Transplantation by Sancén, Niko Alain Cruz, Sanchez-Avila, Juan F, Narro, Graciela E. Castro, Vilatobá-Chapa, Mario, Bulnes, Stefany Mora, Reyes, Elisa Gómez

Get full text

Tu1047 Distribution of SNP Rs 738409 of PNPLA3 Gene and Its Association With Metabolic Syndrome in Mexican Population With Chronic HCV by Castro-Gomez, Jose F, Sixtos-Alonso, Maria-Sara, Cantu-LLanos, Ernesto, Sanchez-Avila, Juan F

Get full text

Latin American Association for the Study of the Liver (LAASL) Clinical Practice Guidelines: Management of Hepatocellular Carcinoma by Méndez-Sánchez, Nahum, MD.,MSc,PhD, Ridruejo, Ezequiel, Alves de Mattos, Angelo, Chávez-Tapia, Norberto C, Zapata, Rodrigo, Paraná, Raymundo, Mastai, Ricardo, Strauss, Edna, Guevara-Casallas, Luis Gonzalo, Daruich, Jorge, Gadano, Adrian, Parise, Edison Roberto, Uribe, Misael, Aguilar-Olivos, Nancy E, Dagher, Lucy, Ferraz-Neto, Ben-Hur, Valdés-Sánchez, Martha, Sánchez-Avila, Juan F

“…AbstractHepatocellular carcinoma (HCC) is the fifth most common cancer in the world and the third most common cause of cancer death, and accounts for 5.6% of…”
Get full text

Two years of lamivudine therapy in anti-HBe-positive patients with chronic hepatitis B by Buti, M., Cotrina, M., Jardi, R., De Castro, E. Cruz, Rodriguez-Frias, F., Sánchez-Avila, F., Esteban, R., Guardia, J.

“…There is no standard therapy for patients with anti‐HBe‐positive chronic hepatitis B. The aims of this study were to analyse the efficacy of lamivudine therapy…”
Get full text

Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-week interim results of a pilot study by POO, Jorge Luis, SANCHEZ-AVILA, F, KERSHENOBICH, D, GARCIA-SAMPER, X, GONGORA, J, URIBE, M

“…Despite steady progress in antiviral treatment for patients with chronic hepatitis C virus(HCV), many patients still have detectable serum HCV RNA levels by…”
Get full text

Latin American Association for the Study of the Liver Recommendations on Treatment of Hepatitis C by Méndez-Sánchez, Nahum, Paraná, Raymundo, Cheinquer, Hugo, Alves de Mattos, Angelo, Gadano, Adrian, Silva, Marcelo, Pessôa, Mario G, Gomes-Ferraz, Maria L, Soza, Alejandro, Mendes-Correa, M. Cassia, Chávez-Tapia, Norberto C, Dagher, Lucy, Padilla, Martín, Hernandez, Nelia, Sánchez-Avila, Juan F, Contreras, Fernando, Moraes-Coelho, Henrique S, Parise, Edison R, Bessone, Fernando, Uribe, Misael

Get full text

Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-week interim results of a pilot study by POO, JORGE LUIS, SÁNCHEZ-AVILA, F, KERSHENOBICH, D, GARCÍA-SAMPER, X, GONGORA, J, URIBE, M

“…Despite steady progress in antiviral treatment for patients with chronic hepatitis C virus (HCV), many patients still have detectable serum HCV RNA levels by…”
Get full text

New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H by Fernández-Galindo, D. A., Sánchez-Ávila, F., Bobadilla-Morales, L., Gómez-Quiróz, P., Bueno-Topete, M., Armendáriz-Borunda, J., Sánchez-Orozco, L. V.

“…Long‐term treatment with retrotranscriptase (RT) inhibitors eventually leads to the development of drug resistance. Drug‐related mutations occur naturally and…”
Get full text

Differential risk factor patterns for a positive treadmill test among subjects with and without ultrasound-based fatty liver by Chavez-Tapia, Norberto C, Tellez-Avila, Felix I, Valdes-Escarcega, Marisol, Perez-Bautista, Oliver, Lizardi-Cervera, Javier, Méndez-Sanchez, Nahum, Sanchez-Avila, Juan F, Ramos, Martha H, Uribe, Misael

“…Introduction: It is not clear whether the risk factors for CVD in subjects with NAFLD are the same for subjects without NAFLD. We analyze the risk factor…”
Get full text

The Mexican consensus on nonalcoholic fatty liver disease by Bernal-Reyes, R, Castro-Narro, G, Malé-Velázquez, R, Carmona-Sánchez, R, González-Huezo, M S, García-Juárez, I, Chávez-Tapia, N, Aguilar-Salinas, C, Aiza-Haddad, I, Ballesteros-Amozurrutia, M A, Bosques-Padilla, F, Castillo-Barradas, M, Chávez-Barrera, J A, Cisneros-Garza, L, Flores-Calderón, J, García-Compeán, D, Gutiérrez-Grobe, Y, Higuera de la Tijera, M F, Kershenobich-Stalnikowitz, D, Ladrón de Guevara-Cetina, L, Lizardi-Cervera, J, López-Cossio, J A, Martínez-Vázquez, S, Márquez-Guillén, E, Méndez-Sánchez, N, Moreno-Alcantar, R, Poo-Ramírez, J L, Ramos-Martínez, P, Rodríguez-Hernández, H, Sánchez-Ávila, J F, Stoopen-Rometti, M, Torre-Delgadillo, A, Torres-Villalobos, G, Trejo-Estrada, R, Uribe-Esquivel, M, Velarde-Ruiz Velasco, J A

“…Nonalcoholic fatty liver disease (NAFLD) affects nearly one third of the population worldwide. Mexico is one of the countries whose population has several risk…”
Get full text

Sa1632 A GROWING THREAT OF HEPATITIS A AND ASSOCIATED MORTALITY IN MEXICO - A MULTICENTER COHORT by Aguirre-Villarreal, David, Beas-Lozano, Evelyn Lilian, Montes, Mario S., Jasso-Baltazar, Erick A., Fernandez-Ramirez, Alfonso J., Fierro-Angulo, Oscar Manuel, Barradas, Mauricio Castillo, Rizo-Robles, María Teresa Guadalupe, Garcia-Campos, Karenn, Prieto-Nava, José-David, Renteria, Luis Alejandro Rosales, Gonzalez-Huezo, Maria Sarai, Rivera-Chavez, José Guadalupe, Piña, Luis O., Aguirre-Valadez, Jonathan, Gonzalez-Chagolla, Alex, Ramírez-Zamudio, Lizeth Carolina, Sanchez-Avila, Juan F., García-Juárez, Ignacio

Get full text

Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin by Buti, Maria, Sanchez-Avila, Francisco, Lurie, Yoav, Stalgis, Carlos, Valdés, Auristela, Martell, Maria, Esteban, Rafael

“…Pegylated interferon (peginterferon) alfa-2b plus ribavirin achieves a higher sustained response rate in patients with genotype 1 chronic hepatitis C virus…”
Get full text

Extending combination therapy with peginterferon alfa‐2b plus ribavirin for genotype 1 chronic hepatitis C late responders: A report of 9 cases by Buti, Maria, Valdés, Auristela, Sánchez‐Avila, Francisco, Esteban, Rafael, Lurie, Yoav

Get full text

Tu1552 – Prevalence of Hepatitis E Virus Infection in a Cohort of Patients with Liver Transplantation in a High-Volume Center in Mexico by Chaires, Luis G., Garcia-juarez, Ignacio, Sanchez-Avila, Juan F., Kamili, Saleem, Drobeniuc, Jan, Tejada, Alexandra, Aftab, Mahwish, Tepox, Alejandra, Muñoz-Martinez, Sergio G.

Get full text

Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B by Higuera-de-la-Tijera, F, Castro-Narro, G E, Velarde-Ruiz Velasco, J A, Cerda-Reyes, E, Moreno-Alcántar, R, Aiza-Haddad, I, Castillo-Barradas, M, Cisneros-Garza, L E, Dehesa-Violante, M, Flores-Calderón, J, González-Huezo, M S, Márquez-Guillén, E, Muñóz-Espinosa, L E, Pérez-Hernández, J L, Ramos-Gómez, M V, Sierra-Madero, J, Sánchez-Ávila, J F, Torre-Delgadillo, A, Torres, R, Marín-López, E R, Kershenobich, D, Wolpert-Barraza, E

“…Hepatitis B virus (HBV) infection continues to be a worldwide public health problem. In Mexico, at least three million adults are estimated to have acquired…”
Get full text